Fzata, Inc. has been awarded a $7 million grant from the National Institutes of Health (NIH) to develop a groundbreaking oral treatment for chronic visceral pain associated with inflammatory bowel syndrome (IBS). The grant will fund pre-clinical and Phase 1 clinical trials for FZ006, a novel drug candidate based on Fzata’s BioPYMTM platform technology.
When Samantha Sprunger, a woman with Irritable Bowel Syndrome (IBS), embarked on a trip to Zurich, her best friends, Lauren Turner and Arno Groll, presented her with a unique and thoughtful gift: a toilet map. This map ensured that Sprunger could navigate the unfamiliar city with ease, reducing her anxiety and allowing her to fully enjoy her vacation. The viral video showcasing this heartwarming gesture has inspired many travelers with IBS to consider similar planning for their own trips.
